Stockreport

Novo Nordisk expands diabetes cell therapy partnership with Aspect Biosystems [Yahoo! Finance Canada]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Aspect will ?lead development and manufacturing and will commercialize the therapies, while Novo Nordisk will ?retain certain options and rights to expand its role late [Read more]